Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 3

Issues

Serum Protein 90K/Mac-2BP Is an Independent Predictor of Disease Severity during Hepatitis C Virus Infection

Eva M. Kittl / Jörg Hofmann / Gerold Hartmann / Christian Sebesta / Franz Beer / Kurt Bauer / Klaus R. Huber
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.029

Abstract

The serum protein designated 90K/Mac-2BP has been found at elevated concentrations in the sera of patients with various types of cancer and viral infections. The importance of the 90K/Mac-2BP serum concentrations in predicting the response towards interferon-α treatment for hepatitis C virus (HCV) infection prompted us to utilize a new ELISA for soluble human 90K/Mac-2BP to monitor the serum concentrations of this protein in our HCV-positive patients. Seventy HCV-PCR and anti-HCV antibody positive patients were analyzed for their serum levels of aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, cholinesterase, HCV-viral load, viral subtypes, and 90K/Mac-2BP. On correlation of age and 90K/Mac-2BP levels, we found an apparent correlation that was proved rather to be a strong dependence of 90K/Mac-2BP concentrations on disease severity/duration, which increases with age. Multiple correlation analysis demonstrated the independent nature of 90K/Mac-2BP concentrations, underscoring the potential high utility of this new marker. Our data corroborate the potential of the scavenger receptor family protein 90K/Mac-2BP as an independent predictor of disease severity during HCV infection.

About the article

Published Online: 2005-06-01

Published in Print: 2000-03-25


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 3, Pages 205–208, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.029.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Vuokko Loimaranta, Jussi Hepojoki, Olli Laaksoaho, and Arto T. Pulliainen
Journal of Leukocyte Biology, 2018
[2]
Rui Chen, Yexiong Tan, Min Wang, Fangjun Wang, Zhenzhen Yao, Liwei Dong, Mingliang Ye, Hongyang Wang, and Hanfa Zou
Molecular & Cellular Proteomics, 2011, Volume 10, Number 7, Page M110.006445
[3]
Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Christian M. Helmes, Andreas O. Doesch, Marcus E. Kleber, Hugo A. Katus, and Winfried Maerz
Atherosclerosis, 2017, Volume 260, Page 121
[4]
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, and Zakaria Y. Abd Elmageed
Biomarkers, 2016, Page 1
[5]
Kuan-Ting Liu, Yao-Hua Liu, Yen-Hsu Chen, Chun-Yu Lin, Chung-Hao Huang, Meng-Chi Yen, and Po-Lin Kuo
International Journal of Molecular Sciences, 2016, Volume 17, Number 6, Page 832
[6]
Brian J. Hare, Eric Haseltine, Mark Fleming, Daniel Chelsky, Laura McIntosh, Rene Allard, and Martyn Botfield
Journal of Proteomics, 2015, Volume 116, Page 59
[7]
J. Hepojoki, T. Strandin, U. Hetzel, T. Sironen, J. Klingstrom, J. Sane, S. Makela, J. Mustonen, S. Meri, A. Lundkvist, O. Vapalahti, H. Lankinen, and A. Vaheri
Journal of General Virology, 2014, Volume 95, Number Pt_11, Page 2356
[8]
Zoe Raglow, Carly Thoma-Perry, Richard Gilroy, and Yu-Jui Y. Wan
Liver International, 2013, Volume 33, Number 7, Page 991
[9]
Sophie Girard, Philip Shalhoub, Pascal Lescure, Abdelmajid Sabile, David E. Misek, Samir Hanash, Christian Bréchot, and Laura Beretta
Virology, 2002, Volume 295, Number 2, Page 272
[10]
Omer Kalayci, Esra Birben, Nicola Tinari, Tsuyoshi Oguma, Stefano Iacobelli, and Craig M. Lilly
Annals of Allergy, Asthma & Immunology, 2004, Volume 93, Number 5, Page 485
[11]
Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Christophe Moreno, Thierry Gustot, and Hans Van Vlierberghe
European Journal of Gastroenterology & Hepatology, 2011, Volume 23, Number 8, Page 701
[12]
Palma Aurelia Iacovazzi, Adriana Trisolini, Domenico Barletta, Silvana Elba, Onofrio Giuseppe Manghisi, and Mario Correale
Clinical Chemistry and Laboratory Medicine, 2001, Volume 39, Number 10
[13]
Kin Jip Cheung, Louis Libbrecht, Kelly Tilleman, Dieter Deforce, Isabelle Colle, and Hans Van Vlierberghe
European Journal of Gastroenterology & Hepatology, 2010, Volume 22, Number 9, Page 1066
[14]
K. J. Cheung, K. Tilleman, D. Deforce, I. Colle, and H. Van Vlierberghe
Journal of Viral Hepatitis, 2009, Volume 16, Number 6, Page 418
[15]
R. V. Warke, A. Becerra, A. Zawadzka, D. J. Schmidt, K. J. Martin, K. Giaya, J. H. Dinsmore, M. Woda, G. Hendricks, T. Levine, A. L. Rothman, and I. Bosch
Journal of General Virology, 2008, Volume 89, Number 7, Page 1605
[16]
Jens Koopmann, Paul J. Thuluvath, Marianna L. Zahurak, Troels Z. Kristiansen, Akhilesh Pandey, Richard Schulick, Pedram Argani, Manuel Hidalgo, Stefano Iacobelli, Michael Goggins, and Anirban Maitra
Cancer, 2004, Volume 101, Number 7, Page 1609
[17]
Yoshitomo Ozaki, Keiichi Kontani, Jun Hanaoka, Tokuhiro Chano, Koji Teramoto, Noriaki Tezuka, Satoru Sawai, Shozo Fujino, Tatsuhiro Yoshiki, Hidetoshi Okabe, and Iwao Ohkubo
Cancer, 2002, Volume 95, Number 9, Page 1954

Comments (0)

Please log in or register to comment.
Log in